About Us
Catalyzing Global Healthcare Innovation
Hiranandani & Wang Capital Berhad is a strategic healthcare investment firm focused on high-growth, high-impact ventures across the healthcare value chain. We invest not only capital, but also expertise and infrastructure, partnering deeply with innovators to unlock scalable, science-backed solutions that transform patient outcomes.
Our Mission
Investing in solutions that improve lives globally.
At Hiranandani & Wang, our mission goes beyond funding — we aim to catalyze transformation in global healthcare by empowering ventures that combine scientific innovation with commercial scalability.
01
Science-Backed, Commercially Scalable Models
At Hiranandani & Wang, we invest in ventures built on solid scientific research with the potential to scale commercially. Our focus is on healthcare innovations that combine rigorous R&D and defensible intellectual property with clear paths to market adoption. Whether it’s regenerative medicine, diagnostics, or biotech, we seek out solutions that are not only medically impactful but also economically sustainable.
02
Partner for Long-Term Value and Trust
We take a hands-on, collaborative approach to investment, working closely with our portfolio companies over a 5–7 year horizon. Our involvement spans from early-stage structuring and regulatory support to distribution planning and IP strategy. This deep engagement is grounded in long-term partnership and trust, ensuring that companies grow with both integrity and resilience.
03
Bridge Markets Through Strategic Alignment and Integration
Our global footprint allows us to help companies seamlessly expand across borders. By leveraging international capital, regulatory insight, and a decentralized operational infrastructure, we connect emerging innovations to mature markets. This integration unlocks new opportunities for scale, access, and global healthcare impact.
Capital deployment strategy
01
Equity Investments
They provide growth capital to early-to-mid stage firms, focusing on companies that have strong scientific foundations and scalable business models. These investments are aimed at accelerating product development, commercialization, and market expansion.
02
Joint Ventures
The firm actively pursues cross-border or commercial execution partnerships, helping healthcare companies enter new markets or expand their reach. These JVs are structured to combine local insight with global infrastructure, ensuring strategic and operational alignment.
03
M&A-Based Models
Hiranandani & Wang also pursues mergers and acquisitions to drive strategic growth, focusing on consolidating smaller players, integrating complementary businesses, and scaling operations for global competitiveness. This approach helps build stronger, more unified healthcare platforms.